<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 328 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page327.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=328">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 328 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 328</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=328"><img src="../thumb/328.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Endocrine System - 19.1.2                                                      2020-04 / 291
       Contraindications: Sulfonylur.& sulphonamide hypersens.,   antidiabet./switch.pt.from max.dos.of anoth.oral antidiab. Improv.   Side effects: Common: GI disords., rash, prurit. Very rare: Urti-
       pregn.& lactat., imp.liv.funct., sev. imp.ren.funct., childr., Type 1 diab.  diab.contr.is assoc.with high. insul.sensitiv.allow.for reduc.requirem.  car., erythema, anaem., maculopap. rash, bullous reacts., leucopaen.,
       mellit., signific. acidos., sev.burns., diabet.coma, diabet. ketoacidos./  theref. dos. reduct.must be consid.in time.  thrombocytopaen., granulocytopaen., rais. liv. enzym., hepatit., trans.
       hyperosmol.nonketot.coma, maj. surg., sev.trauma, galact.intol.hist.,   Contra-indications: Sulphonylurea or other sulphonamide hyper-  vis.disturbs.esp.init. Unknown freq: Hypoglycaem.sympt.incl. head-
       Lapp lact. defic./gluc.-galact.malabsorpt.  sens., safety in pregn.& lactat. not est., imp.liv.funct., childr., insul.-  ache, reduc. awaren., lassit., trem., sens. disords., dizzin., delir., con-
       Side effects: Bld.dyscras., CNS effs., hypoglycaem., GI disturbs.,   depend.(type 1) diab. mellit., rare heredit.galact.intol.probl., Lapp   vuls., shallow resp., bradycard., drowsin., loss.of consciousn.poss.
       polyuria, hepato-bil. disords., blurr.vis./accomodat.changes, ery-  lact.defic., gluc.-galact. malabsorpt.  result.in coma, signs of adrenerg.count.-regulat. incl.sweat., anx.,
       thema multiforme, photosens., prurit., urticar., maculopap. rash,   Side-effects: Hypoglycaem.somet.life-threat., adrenerg.counter-  tachycard., hypertens., ang.pect., dysrhythm.
       hypersens.reacts., tox.derm. necrolys., allerg.vasculit.  regul.signs, tempor.vis.impairm. esp.at start of treatm., GI disturbs.  Warnings and special precautions: Hospitalisat. reqd. if hypo-
       Special precautions: Incr.CV mortal.as compar. to diet alone/diet   incl.full epigastr. sensat., hepatit., liv.enzym.elev.&/cholestas.&   glycaem.episod.sev./ prolong., assoc.incr.CV mortal.as compar.to
       & insulin., discont.ther.if cholestat. jaund.evid, monit.for hypogly-  jaund. poss.progress.to liv.fail., potent.life-threat. bld.dyscras.,   diet alone/ diet & insul., elderly, uncooperat.pt./ malnutrit./ irreg.or
       caem. esp.dur.init.wks.of treatm., predispos. hypoglycaem. condits.,   skin rash, urticar./itch poss.devel.into ser. reacts./ shock, allerg.  skipp.meals/fast.per./diet chang./ exerc.& carbohydr.intake imbal./
       consid.temp.change to insul.und.except.stressors.  vasculit., light hypersens. of skin, hypo-/hyperglycaem. esp.init./  cert. endocr. disords./concom.cert.other.meds./ren. funct. deterior.
       Drug interactions: Hypoglycaem.poss.with alcoh./ allopurin./  alt.ther. /irreg. admin.   are fact.support.hypoglycaem., bld. gluc.poss.deterior.dur.except.
       anabol.ster.& androg./ACE inhibit./disopyram./chloramphenic./sul-  Special precautions: Incr.CV mortalit.risk with oral hypoglycaem.  stress per.incl. trauma/ fev./infect./surg.& theref.tempor.chang.to
       phonam./ fluoroquinol./tetracycl./clonidine/coumar.derivat./fluoxet./   compar.to diet alone/diet plus insul., pt.to be inform.of benef.vs   insul. poss.necess., hypoglycaem.can recur even if init. meas.prove
       fenfluram./miconaz./ketoconaz./ itraconaz./ voriconaz./cimetid./ra-  risk of ther./alt. treatm., temp.change to insul.poss.necess.in stress   effect., discont.ther.if cholestat. jaund. appears.
       nitid./clofibr./ insul. & other oral antidiab.agents/MAOI/ salicylat./   situat.,reg.measurem.of bld.& gluc.lev., reg. determ. of proport.of gly-  Interactions:  Miconazole/fluconazole/ ketoconazole/
       NSAID’s/probenec./quinidine./ quinine/ sulphinpyraz.  cat.Hb, notif.phys.immed.if too high/extra dos.been taken, improv.  phenylbutazone/ß-block./ cimetidine/ ranitidine/other diab. agents/
       Hyperglycaem.poss.with adrenal.& other sympathomimet. agents/  contr. assoc. with incr.insulin sensitiv.theref.consid.dos. adjustm. in   ACE-inhib./ alcoh. incr.hypoglycaem.risk., avoid alcoh./ meds. cont.
       corticoster./Ca chann. block./parenter.diazoxide/diuret./glucagon/   time, fact.favour.hypoglycaem., lifestyle chang., imp.ren.funct., phys.  alcoh., incr.bld.gluc.low.lev.by danazol/ chlorpromazine/glucocortic./
       isoniaz./Li/oestrog.& progester./phenothiaz./ phenytoin /rifampic./  notif.in case of urticar./hypoglycaem. episod., uncompens. disords.   salbutamol/ terbutaline/ other ß-adrenerg.agon./ephedr./ pseu-
       thyr.horm. barbit.prolong. eff., eff.decr.by beta-block., sympatholyt.  of endocr.syst.aff.carbohydr. metabol./ counter-regulat.of hypogly-  doephedr & common cold preps.
       meds. blunt signs of adrenerg.respons.to hypoglycaem. & imp.   caem., insul.treatm.of choice in non-insul.depend.diab.mellit.with
       mechan.control.norm.physiologic. respons. to fall in bld.gluc., cour-  hepat. & ren.dysfunct., G6PD-defic.  GLUCONORM, (Unicorn) Be-Tabs [P/S]
       mar.derivat.eff. poss.weak./potent.  Drug interactions: Poss.bld.gluc.chang.with CYP2C9 induc./in-  Metformin HCl.
                                                                  Indications: Type II diab.mellit.when diet.fail. esp. if pt.overweight.,
       EUGLIM, Zydus [P/S]           hib., potent.of effs.poss.with insul. & other oral antidiab./MAOI/  alone as init.ther./in combinat. with a sulphonylurea, insulin-depend.
                                     ACE inhibit./ miconazole /anabol. ster./male sex horm./para-ami-
       Glimepiride                   nosalicyl.acid/chloramphenicol/pentoxifylline (high parent.dos)/  diabet.in combin.with appropr.diet.
       Indications: Hyperglycaem.in type 2 diab.mellit. not control.by   coumar.derivats./ phenylbutazone/ azapropazone/ oxyphenbuta-  (S3) TABS, 41/21.2/0071, 0072
       diet. & exerc.alone.          zone/ cyclophospham./disopyramide/quinolones/ salicylates/ sul-  714525-001: 500 mg, 100, R44,71
       (S3) TABS, 40/21.2/0757, 0758, 0759  phinpyrazone/fibrates/sulfonamide antibiot./ fluoxet./tetracycl./  714526-001: 850 mg, 60, R50,61
       710207-001: 1 mg, 30, R68,13  guanethidine/ ifosfamide/ fluconazole/clarithromycin, weaken.of   Dosage: Admin.in div.dos.with meals.
       710208-001: 2 mg, 30, R134,81  eff.with acetazolamide/protract.use of laxativ./ barbitur./high dos.  Adults: 500 mg tabs: Init.500 mg 3x/day. May be incr.up to max.
       710209-001: 4 mg, 30, R205,86  of nicotin.acid/ corticoster./ oestrog.& progestog./diazoxide/ phe-  of 2 tabs.3x/day (3 g dly). Diab. contr .may be obtain.with.few days
       Dosage: Indiv.accord.to bld.gluc.lev.at low.dos.to achiev.desir.  nothiazines/ diuret./ phenytoin/adrenal.& other sympathomimet./   but may take up to 2 wks. Dos.may be reduc.when contr.obtain.
       metabol.contr. Sngl.dly.dos.usual. adeq. to provide metabol.con-  rifampicin/glucagon & thyroid hormones, H 2-recept.antagon./ß-  850 mg tabs: Init.850 mg dly.incr.grad.to max.of 3 tabs.dly. unt.
       trol over 24 hrs.             block./clonidine & reserpine may either potent./dimin.effs., signs   diab.contr.obtain.
       Init: 1 mg once dly.which may be grad.incr.at interv. of 1-2 wks.  of adrenerg.counter-regulat.to hypoglycaem.may be reduc./ absent   Contra-indications: Diabet.coma/ketoacidos. hist., imp.ren.
       by 1 mg-2 mg-3 mg-4 mg-6 mg. Max.dos.8 mg/day. Usual.dly.dos:   under the influence of sympatholytic, alcoh.may potent./weak.eff.,   funct., chron.liv.dis., card.fail., recent MI, hist.of/states assoc.
       1-4 mg taken bef. a substant.breakf./1st main.meal of the day.  eff.of coumarin deriv.potent./weaken.  with lact.acidos. eg.shock / pulm.insuffic., alcohol., condits.assoc.
       Improv.diab.contr.is assoc.with improv.insul. sensitiv. theref.dos.  with hypoxem., pancreatit., safety & effic.not est.in childr., pregn.,
       reqd.may decr.over time       GLICLAZIDE UNICORN 80, (Unicorn) Servier [P/S]  safety in lactat.not est.
       Contraindications: Sulphonylurea/other sulfonamide hypersens.,   Gliclazide.  Side-effects: Vit.B12 & folic acid absorpt. decr.  dur.longt.use, lact.
       pregn., lactat., imp.liv. funct., mod.to sev.imp.ren.funct., childr.,   Indications: Maturity onset diabet.mellit.where diet.managem.  acidos., metall.taste, GI disturbs.
       type 1 diab. mellit.          alone insuffic.              Special precautions: Poss.dos.reduct.with cimetidine, poss.anti-
       Side effects: Bld.dyscras., CNS effs., hypoglycaem., signs of adr-  (S3) TABS, J/21.2/190  coag.dos.adjustm., elderly, ther.assoc.with incr.CV mort.risk, assess
       energ.excess, GI disturbs., polyuria, imp.hepat.funct., blurr.vis./ ocul.   719463-009: 80 mg, 60, R61,15  risk fact. assoc.with lact.acidos.& discont.ther./treat as med.emerg.if
       accomodat.changes esp.at start of treatm., skin reacts., allerg.reacts.  Dosage: Indiv. Dos.accord.to sever.of diab.state. Mild cases:1 tab.   susp., reg.ren.funct.monit., discont. 2-3 days bef.elect.surg./clinic. in-
       which may develop into life threaten.reacts.  Sev.cases: 4 tabs.admin.in 2 div. dos. pref.with meals. Mostly 1 tab   vestigat. such as IV urograph./angiograph.& reinst.aft.ren.funct. con-
       Special precautions: Incr.CV mortalit.report. with oral sulphonylu-  2x/day morn.& even. May be used with insul.in insul.-depend. diab.   tr. regain., not advis.in condits.caus.dehydrat./ ser.infect./trauma or
       rea antidiabet.esp.in high risk myocard. ischaem.pts., meals should   Great.CV mortalit.risk with a concom. biguanide.  low cal.intake, annual Vit.B12 lev.dur.longt.ther., bld.gluc.monit.with
       not be missed after taking tabs., poss.dos.adjustm.with chang. in   Contraindications: Keto-acidos./sev.ren./ hepat./ adren./ thyroid   concom. sulphonylur., stabilis.pts.in hosp.if concom. insulin admin.
       pts.weight/lifestyle/meds., when substit. with other oral antidiabet.  dysfunct., sulphonylurea intol., unstabl. diabet., safety in pregn.not   Drug interactions: Reduc.ren.clear.with cimetidine, poss.hypogly-
       meds.the same dos. proced. as for init.dos.recomm.as no exact dos.   est., juven. diabet.  caem.with sulphonylur., poss.interact.with anticoags.
       relationship avail., hypo-/hyperglycaem.poss.imp. alertn. & reacts.  Side effects: Weight chang., hypoglycaem./skin reacts., head-
       esp.when init./alter.dos., hypoglycaem. risk incr.in init.wks.of treatm.  ache, GI disturbs., dizzin., weakn., paraesthes., sens.reacts./fev.,   GLUCOPHAGE, (Biopharma Div) Merck [P/S]
       theref. monitor. essent., fact.favour.hypoglycaem., endocr. disords.   jaund., bld. disords.  Metformin HCl.
       involv.thyroid/anter.pituit/adren.glands, when counter-regulat horm.  Warnings and special precautions: Assoc. incr. CV mortal. as   Indications: NIDDM when diet managem.& exerc. alone does not
       respons.to hypoglycaem. blunt/attenuat., convert pt.tempor.to insul.   compar.to diet alone/diet & insul., ren.dysfunct., hypoglycaem.risk   result in adeq.glycaem. control. May be used as monother/combin.
       to maint.good metabol.control dur.except. stressors.  with combin. ther., hypoglycaem.agents dos.adjustm. poss. requir.   with other oral anti-diabet.agents/insulin in adults. In childr.over 12
       Drug interactions: Hypoglycaem.with allopurin./ anabol. ster.&   with infect./trauma/shock/ aft. anaesthes., insul.ther.to be substit.  yrs.& adolesc.used as monother/ combin.with insulin.
       androg./ACE inhibit./disopyramide/ chloramphenicol/sulphona-  by oral hypoglycaem. in case of maj.surg.  (S3) TABS, [P/S] G3244, F/21.2/145, 37/21.2/0272
       mide/quinolones/ tetracycl./ coumar.anticoag.derivat./fluoxet./   Interactions: Sulphonamid./salicylat./ phenylbutazone/ ß-adreno-  729159-019: 500 mg, 90, R64,97
       cyclophospham./ ifosfamide/trofosfamide/ fenfluramine/ azole   cept.block.agents/ MAOI/ chloramphen./ketoconazole/miconazole/   729167-003: 850 mg, 60, R78,91
       antifung./ß-block./ fenyramidol/ clofibrate/guanethidine/insul.&   clofibrate/ halofenate, cyclophosphamide/ dicoumarol/ cimetid./may   703909-001: 1000 mg, 60, R85,69
       other oral antidiab./MAOI/para-aminosalicyl.acid/ pentoxifylline   potent hypoglycaem. act., adrenaline/oestrog./thiaz.diuret./ corti-  Dosage: Admin.in div.dos.with/aft.food.
       (high parent.dos)/phenylbutazone/ azapropazone/ oxyphenbuta-  coster. may dimin.act., ß-blocks.may mask hypoglycaem. sympt. &   Adults: Init.1000-850 mg 2x/day or 500 mg 3x/ day. If contr.in-
       zone/probenecid/ sulphinpyrazone/ tritoqualine.  inhib.norm.physiolog. respons.to hypoglycaem.  compl.caut.incr.to max.of 2 550 mg/ day. Poss.reduc.dos.once contr.
       Hyperglycaem. with acetazolamide/adrenal.& other sympathom-  Childr.12 yrs & old.& adolesc: Start.dos: 500-850 mg once dly.
       imet./barbitur./corticoster./ diazoxide/ diuret./ glucagon/isoniazid/  GLICLAZIDE UNICORN MR 30, (Unicorn) Biogaran [P/S]  Adjust accord.to bld.gluc. measurem. aft.10-15 days. Max: 2 000 mg
                                     Gliclazide.
       protract. laxat./high dos.of nicotin.acid/oestrog.& progestog./ phe-  dly.in 2-3 div.dos.
       nothiazines/phenytoin/rifampicin & thyroid hormon., eff.of coumarin   Indications: Type 2 diabet.with diet.meas./ lifestyle chang.& exerc.  Contraindications: Diabet.coma & ketoacidos., diabet. pre-
       deriv.potent./ weaken., H 2-recept.antagon./ß-block./alcoh/ clonidine   when diet.meas./ lifestyle & exerc.alone insuffic.  coma, ren.fail./dysfunct., ac.condits. with potent. to alt.ren.funct.
       & reserpine may either potent./weak. eff., sympatholytic.may blunt   (S3) MR TABS, 38/21.2/0224  eg.dehydrat/sev. infect./ shock/intravasc.admin.of iodinat.contrast
       signs of adrenerg. hypoglycaem. respons.  721692-001: 30 mg, 60, R61,19  agents, ac./chron.dis.poss.caus.tiss.hypox.e.g. card./ resp. fail./
                                                                  rec.MI/shock, hepat.insuffic., ac. alcoh.intoxicat., alcohol., pregn.&
                                     Dosage: Adults: Dly.dos.30-120 mg/day as sngl. dly. dos.with
       GLAMARYL, Winthrop [P/S]      breakf. Adjust.accord.to indiv. metabol. respons. Should a dos.  lactat., pancreatit.
       Glimepiride                   be forgot.do not incr.dos.the next day. Init.recomm dos: 30 mg   Side effects: Decr.Vit.B12 absorpt.dur.longt. ther., GI disturbs., skin
       Indications: Non insul.depend.diabet.mellit.not control.by diet.&   once dly.with breakf. If fast.bld.gluc.lev.not decr. satisfact. incr.dos.  reacts., lact.acidos., metal. taste, decr. folic acid serum lev., hepatit.
       exerc.alone, combin.ther.with metformin when contr.with max.dly   progress.to 60 mg,90 mg or 120 mg/day with 1 mnth.interv.betw.  Special precautions: Discont.& hospitalis.if metabol. acidos.
       dos. of either glimepiride /metformin not adeq.  increm. except where bld.gluc.lev.not decr.aft.15 days when an incr.  suspect., monit.ren.funct.bef.init. treatm. & regul.thereaft.esp.el-
       (S3) TABS. 33/21.2/0387, 0388, 0390  poss.at end of 2 wk.of treatm. Max. dly.dos: 120 mg. Prev.untreat.  derly, condits.where ren.funct.may become imp., discont.ther.bef.
                                            nd
       704362-001: 1 mg, 30, R97,42  pts.to start with 30 mg dos.  intravasc. admin.of iodinat.contrast agents allow. 48 hr. interv &
       704363-001: 2 mg, 30, R185,17  Gliclazide replacem.ther: 80 mg gliclazide = 1 tab. Gliclazide   re-eval.ren.funct.bef.re-comm.ther., discont. 48 hrs.bef.elect.surg.
       704364-001: 4 mg, 30, R342,38  Unicorn MR 30.              with gen.anaesthes. & reinstit.not earlier than 48 hrs aft., contin.
       Dosage:.Indiv.accord.to bld.gluc.lev.at low.dos.to achiev.desir.me-  Other sulphonylur.replacem.ther: When tfd. consid. dos.& half-  diet with regul.carbohydr.intake dur.day/energy restrict. diet for over-
       tabol.contr. Do not. take larg.dos. subseq. when dos.skipp. Swall.  life of prev.oral hypoglycaem. If chang. from anoth.oral sulphony-  weight pts., reg.diabet.monit. tests, poss.hypoglycaem.with concom.
       whole .Init.dos: usual.1 mg once dly. If necess.may be incr.grad. at   lur.with prolong. half-life a therapeut.window of a few days poss.   insulin/ sulphonylureas, annual monit.of Vit B12 & folic acid, dur.
       interv. of 1-2 wks.by 1 mg-2 mg-3 mg-4 mg-6 mg. Max.dos.8 mg/  necess. to avoid addit.eff.& hypoglycaem.risk. Dur. changeover   longt.ther., condits.caus.dehydrat., infect./ trauma/low calor.diet,
       day. Usual.dly.dos: 1-4 mg taken immed.bef.a substant.breakf./1st   init.30 mg/day incr.increm.accord.to pt. metabol.evolut.  stabilisat.of pts.on combin. ther.in hosp., confirm type 2 diab.mellit.
       main.meal of the day norm.at same time dly.. Do not skip meals   Other oral antidiabet.combinat: Check diab. contr. with bld.sugar   diagnos. in childr.bef. init. treatm., monit.growth & puberty in paed.
       aft.tabs.taken. Sngl.dly.dos.norm.suffic.to provide metabol.control   read.when combin.with alpha glucosid. inhibit./insul. Great.risk of   pts. esp.the pre-pubescent.
       over 24 hrs .Combin.ther.with metformin may be init.if pt. not adeq.  CV mortal. when combin.with biguanid.  Warnings: Reduc.incid.of lactat.acidos.by assess. assoc.risk fact.
       contr.with max. dly glimepiride dos. Init.low.dos.titrat.up depend.  Contraindications: Other sulphonylur./ sulphonam. hypersens.,   eg.poor.controll.diab./ketosis, prolong. fast./excess.alcoh.intake/
       on desir.lev.of metab.contr.up to max.dos. Treatm. usual.longterm.   type 1 diab., diab. ketoacidos., diab.pre-coma/coma, childr., sev.   hepat.insuffic. & other condits.assoc.with hypox., poss.dos. ad-
       Recomm.proced.same as for init.dos.if substit.Glamaryl for other oral   ren./ hepat.insuff., safety in pregn.& lactat.not est.  justm. of anticoags.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page327.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page323.html">323</a>&nbsp;&nbsp;&nbsp;<a href="page324.html">324</a>&nbsp;&nbsp;&nbsp;<a href="page325.html">325</a>&nbsp;&nbsp;&nbsp;<a href="page326.html">326</a>&nbsp;&nbsp;&nbsp;<a href="page327.html">327</a>&nbsp;&nbsp;&nbsp;<a href="page328.html">328</a>&nbsp;&nbsp;&nbsp;<a href="page329.html">329</a>&nbsp;&nbsp;&nbsp;<a href="page330.html">330</a>&nbsp;&nbsp;&nbsp;<a href="page331.html">331</a>&nbsp;&nbsp;&nbsp;<a href="page332.html">332</a>&nbsp;&nbsp;&nbsp;<a href="page333.html">333</a>
             </td>
             <td width="35%"><a href="page329.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page329.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
